Non-Dilutive Funding: Finding It, Getting It, and Using It Strategically to Move Your Company Forward
Date: Wednesday March 6, 2013 | Part 1 of a 2-part series. Part II , focused on venture capital, will be held at LSINW 2013 Time: 7:30 AM - 12 Noon Where: The Agora, an Alexandria Conference Center (WBBA Offices, 1551 Eastlake Ave. E, Seattle, WA 98102)
Topic Description: It’s no secret that funding a life science business is harder than ever. The contraction of venture capital and cuts to federal grant budgets have made securing non-dilutive funding more difficult, yet ever more crucial to validating technology and reducing risk early on. Don’t miss this event if you want learn more about the varied sources of non-dilutive capital available to life science companies in Washington and how best to go about finding it, getting it, and using it smartly. REGISTER TODAY! Learning Objectives: How do you find out about non-dilutive funding sources and what they fund? What do funders look for in funding proposals? How do you create, establish and maintain a grant budget? How do you align project flow with additional grants and follow-on funding? When can you use grants strategically to fund specific milestones? What service providers do you need to assist with obtaining and managing non-dilutive capital?
Who Should Attend: Early stage company leaders Researchers, students and postdocs working on commercializable ideas and products Grant writers and project managers Service providers who support and manage grant-funded projects
Our Expert Panelists: Susan Ashe, Executive Director, HSSA, Spokane Allison Formal, Vice President, Research, Business Development, The Leukemia & Lymphoma Society Dave Cronsier, Vice President, Engineering, PhysioSonics Michael Hite, President & CEO, Impel NeuroPharma Christiana DelloRusso, Director, Commercialization, WBBA Jim Katzaroff, President & CEO, AMIC John D